Now showing items 1-2 of 2

    • Immunotherapy for Alzheimer’s disease: hoops and hurdles 

      Lemere, Cynthia A (BioMed Central, 2013)
      Alzheimer’s disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide. Currently, there is no cure or way to prevent this devastating disease. Extracellular plaques, containing ...
    • Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges 

      Cynis, Holger; Frost, Jeffrey L.; Crehan, Helen; Lemere, Cynthia A. (BioMed Central, 2016)
      Immunization against amyloid-β (Aβ) peptides deposited in Alzheimer’s disease (AD) has shown considerable therapeutic effect in animal models however, the translation into human Alzheimer’s patients is challenging. In ...